Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2

Hepatitis C Clinical Trial

Official title:

Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03320889
• Other study ID #: 17-057
• Status: Completed
• Phase: N/A
• Start date: October 30, 2017
• Est. completion date: August 26, 2019

Study information

• Verified date: August 2019
• Source: TriHealth Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to assess patients' attitudes and knowledge of Hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.

Description:

The study will compare the effectiveness of providing HCV education by providing a pamphlet and expert education compared to providing a pamphlet only. The information gained in completing this study will help the medical community improve patient education on the disease and specifically understand how the medical community can best serve pregnant patients with opiate dependence burdened by Hepatitis C.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 115
• Est. completion date: August 26, 2019
• Est. primary completion date: August 26, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Study population includes Faculty Medical Center obstetrics and postpartum patients enrolled in the HOPE program who are 18 years old or older.

• The study will include patients with and without a Hepatitis C diagnosis.

• Patients will be recruited at their routine office visits and/or during any admissions to the hospital.

Exclusion Criteria:

• Patients who do not speak and understand English.

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis C
• Opioid-Related Disorders

Intervention

Other:
• Educational Intervention
Patients will be randomized to a group that receives the pamphlets only and a group that receives the pamphlets and has an expert educator review that pamphlets with them and answer questions.

Locations

Country	Name	City	State
United States	Good Samaritan Hospital	Cincinnati	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
TriHealth Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Questions Scored Correct on the Hepatitis C Knowledge Survey	Number of questions scored correct on the Hepatitis C knowledge survey	2-8 weeks after study intervention